A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma

Background. Patients with recurrent synovial sarcomas have few options for systemic therapy. Since they express large amounts of endogenous CT (cancer testis) antigens such as NY-ESO-1, we investigated the clinical activity of single agent anti-CTLA4 antibody ipilimumab in patients with advanced or...

Descripción completa

Detalles Bibliográficos
Autores principales: Maki, Robert G., Jungbluth, Achim A., Gnjatic, Sacha, Schwartz, Gary K., D'Adamo, David R., Keohan, Mary Louise, Wagner, Michael J., Scheu, Kelly, Chiu, Rita, Ritter, Erika, Kachel, Jennifer, Lowy, Israel, Old, Lloyd J., Ritter, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608267/
https://www.ncbi.nlm.nih.gov/pubmed/23554566
http://dx.doi.org/10.1155/2013/168145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608267/
https://www.ncbi.nlm.nih.gov/pubmed/23554566
http://dx.doi.org/10.1155/2013/168145

Ejemplares similares